Freenome Inc

Freenome Inc., based in South San Francisco, is pioneering the field of early cancer detection by integrating cutting-edge science with artificial intelligence, utilizing the simplicity of a standard blood draw. Their innovative screening platform leverages multiomics technology to identify cancer at its earliest and most treatable stages.

With a strong focus on research and a commitment to advancing clinical programs, Freenome is dedicated to redefining the future of cancer screening through collaboration among passionate creators and ambitious builders. The company emphasizes a multi-disciplinary approach, pushing the boundaries of what is possible in the realm of early cancer detection.

Generated from the website